Latest news with #PharmaClinicalTrialsDatabase
Yahoo
19-05-2025
- Business
- Yahoo
Seasonal Influenza Global Clinical Trials Review 2025
Access key data by region, country, phase, and more. Enhance decision-making and strategy development with this essential analysis for competitive advantage. Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Seasonal Influenza - Global Clinical Trials Review, 2025" has been added to offering. The report offers a comprehensive analysis of the ongoing clinical trials landscape for seasonal influenza. This detailed report provides high-level data pertaining to the number of trials and average enrollment figures in leading countries worldwide. Key features include regional, country-specific (focusing on G7 and E7 nations), phase-based, trial status, endpoint status, and sponsor type coverage of disease clinical trials. Furthermore, it highlights prominent drugs undergoing trials, categorized by the number of ongoing trials. This insight is derived from the proprietary Pharma Clinical Trials Database, which synthesizes data from over 80 sources, including global clinical trial registries, conferences, journals, and news outlets. The database is rigorously updated through a dynamic process to ensure accuracy and relevance. This report empowers decision-makers to craft effective strategies, enabling them to secure competitive advantages in the market. Certain sections may be revised or omitted based on data relevance and availability for the specified disease. Scope: Snapshot of the global clinical trials landscape. High-level data segmented by region, country (G7 & E7), trial status, phase, sponsor type, and endpoint status. Analysis of top companies involved, including detailed listings of trials (titles, phases, and statuses). Documentation of unaccomplished trials (terminated, suspended, and withdrawn) with reasons provided. Trends in trial enrollment over the past five years. The latest news from the past quarter. Reasons to Buy: Guidance on key business strategy formulation regarding investment. Identification of prime locations for clinical trials to optimize time and costs. Top-level analysis of the Global Clinical Trials Market, pinpointing business opportunities. Understanding trial count and enrollment trends on a country level within the global therapeutics market. Interpretation of clinical trial success rates, comparing completed vs. uncompleted trials. Assessment capability of clinical trials on a global, regional, and country-specific scale. Key Topics Covered: Report Guidance Clinical Trials by Region Top Countries Contributing to Clinical Trials Asia-Pacific Europe North America Middle East and Africa Central and South America Clinical Trials by G7 and E7 Countries Proportion of Seasonal Influenza to Infectious Disease Clinical Trials by Phase Clinical Trials by Trial Status In Progress Trials by Phase Clinical Trials by End Point Status Clinical Trials by Sponsor Type Prominent Sponsors and Drugs Latest Clinical Trials News on Seasonal Influenza April 9, 2025: Longhorn Vaccines and Diagnostics Presentation March 24, 2025: Traws Pharma Antiviral Program March 18, 2025: Cidara Therapeutics ICAR 2025 Presentations March 17, 2025: Cidara Therapeutics Preclinical Data Publication Clinical Trial Profile Snapshots Companies Featured GSK plc Novartis AG Johnson & Johnson Novavax Inc CSL Ltd Sanofi Moderna Inc Sinovac Biotech Ltd IQVIA Holdings Inc Thermo Fisher Scientific Inc For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-05-2025
- Business
- Yahoo
Graft Versus Host Disease (GVHD) Global Clinical Trials Review 2025: Unlocking Strategies from GVHD Clinical Trials Across G7 & E7 Regions
Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2025" has been added to offering. The report offers a comprehensive analysis of the GVHD clinical trial landscape worldwide. Presenting top-line data, this report furnishes details about the number of trials and their average enrollment across major countries. It covers trials by region, country (G7 & E7), phase, status, endpoints, and sponsor types. This report also highlights key drugs involved in ongoing trials, curated from the Pharma Clinical Trials Database. This database consolidates information from over 80 global trial registries, conferences, journals, and news sources and is periodically updated through a dynamic process to ensure data accuracy and relevance. The insights provided in this report enhance strategic decision-making and help formulate effective strategies to gain a competitive edge. Scope Provides a snapshot of the global clinical trials landscape, offering top-level data by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type, and End Point Status. Reviews leading companies in the sector and lists all relevant trials with titles, phases, and statuses. Details unaccomplished trials, including terminated, suspended, and withdrawn, along with reasons for uncompletion. Shows enrollment trends over the past five years and shares the latest news from the past three months. Specific sections might be modified based on data availability and relevance to the disease. Reasons to Buy Supports strategic business investment decisions. Identifies optimal locations for cost-effective and timely clinical trials. Provides a top-level analysis of the Global Clinical Trials Market, pinpointing key business opportunities. Clarifies trial count and enrollment trends globally, aiding market understanding. Compares completed with incomplete trials to assist in interpreting clinical trial success rates. Offers an assessment of trials at global, regional, and country levels. Sections may be customized based on data relevancy to the implicated disease. Key Topics Covered: Report Guidance Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Five Countries Contributing to Clinical Trials in Asia-Pacific Top Five Countries Contributing to Clinical Trials in Europe Top Countries Contributing to Clinical Trials in North America Top Five Countries Contributing to Clinical Trials in Middle East and Africa Top Five Countries Contributing to Clinical Trials in Central and South America Clinical Trials by G7 Countries Clinical Trials by Phase Clinical Trials by Trial Status Clinical Trials by End Point Status Subjects Recruited Over a Period of Time Clinical Trials by Sponsor Type Prominent Sponsors Top Companies Participating in Graft Versus Host Disease (GVHD) Therapeutics Clinical Trials Prominent Drugs Latest Clinical Trials News on Graft Versus Host Disease (GVHD) Clinical Trial Profile Snapshots Appendix A selection of companies mentioned in this report includes, but is not limited to: Sanofi Incyte Corp Novartis AG Johnson & Johnson Pfizer Inc Takeda Pharmaceutical Co Ltd Mallinckrodt Plc Roche Holding AG Bristol-Myers Squibb Co Bellicum Pharmaceuticals Inc For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
